Comparative, placebo controlled, double-blind efficacy and safety study in patients with seborrhoeic dermatitis comparing a topical cream containing 2% Nicotinamide combined with either 0%, 0.5% or 1.0% GMCY with the placebo cream.
Latest Information Update: 04 Mar 2016
At a glance
- Drugs ASF 1057 (Primary)
- Indications Seborrhoeic dermatitis
- Focus Therapeutic Use
- Sponsors Astion Pharma A/S
Most Recent Events
- 04 Mar 2016 New trial record